ANVS
Annovis Bio, Inc.
$1.99
+0.07 (+3.65%)
At close · Jul 8
Market Cap
$68.95M
Shares
34,646,868
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2025
Net Income
-$28.85M
-17.3%
FY2025
Diluted EPS
-$1.40
+39.4%
FY2025
Operating Cash Flow
-$25.62M
-17%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|---|
| — | $0 | $0 | $0 | $0 | $0 | $0 | |
| $36.92M | $25.22M | $20M | $38.79M | $16.52M | $8.48M | $3.05M | |
| $4.5M | $4.48M | $6.7M | $6.24M | $9M | $6.06M | $3.59M | |
| $41.42M | $29.7M | $26.69M | $45.04M | $25.51M | $14.54M | $6.64M | |
| -$41.42M | -$29.7M | -$26.69M | -$45.04M | -$25.51M | -$14.54M | -$6.64M | |
| $649.25K | $699.06K | $331.85K | — | — | — | — | |
| $501.25K | $841.06K | $2.1M | -$11.17M | $182.71K | $50.09K | $1.18M | |
| -$40.94M | — | — | -$56.2M | -$25.33M | -$14.49M | -$5.46M | |
| $0 | $0 | — | — | — | — | — | |
| -$40.92M | -$28.85M | -$24.59M | -$56.2M | -$25.33M | -$14.49M | -$5.46M | |
| USD/shares | — | -$1.40 | -$2.02 | -$6.23 | -$3.10 | -$1.90 | — |
| USD/shares | — | -$1.40 | -$2.31 | -$6.23 | -$3.10 | -$1.90 | — |
| shares | — | 20.55M | 12.18M | 9.02M | 8.16M | 7.63M | 6.31M |
| shares | — | 20.55M | 12.24M | 9.02M | 8.16M | 7.63M | 6.31M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.